The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical significance and biomarker potential of MGMT protein measurement in colorectal cancer.
 
Janie Yue Zhang
Other Relationship - Amgen
 
Michael Cecchini
Stock and Other Ownership Interests - Parthenon Therapeutics
Honoraria - Agios; AstraZeneca; Eisai; GRAIL
Travel, Accommodations, Expenses - Agios; AstraZeneca; Eisai; Genentech/Roche
 
Shruti S. Desai
No Relationships to Disclose
 
Kurt A. Schalper
Consulting or Advisory Role - Agenus; Clinica Alemana; Dynamo Therapeutics; EMD Serono; Excite International; Merck; Ono Pharmaceutical; Pierre Fabre; Shattuck Labs; Takeda; Torque
Speakers' Bureau - Bristol-Myers Squibb; BTIG; Fluidigm; Genmab; Merck; Peerview; Takeda
Research Funding - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck; Moderna Therapeutics; Navigate BioPharma; Pierre Fabre; Ribon Therapeutics; Surface Oncology; Takeda; Tesaro
Patents, Royalties, Other Intellectual Property - Patent No. 16/464,010 (PREDICTION OF RESPONSE TO IMMUNE-MODULATORY THERAPIES)